Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
The Lancet Respiratory Medicine2014Vol. 2(7), pp. 539–547
Citations Over TimeTop 1% of 2014 papers
Eitan Kerem, Michael W. Konstan, K. De Boeck, Frank J. Accurso, Isabelle Sermet‐Gaudelus, Michael Wilschanski, J.S. Elborn, Paola Melotti, Inez Bronsveld, Isabelle Fajac, Anne Malfroot, Daniel Rosenbluth, Patricia Walker, Susanna A. McColley, Christiane Knoop, Serena Quattrucci, Ernst Rietschel, Pamela L. Zeitlin, Jay Barth, Gary Elfring, Ellen Welch, Arthur Branstrom, Robert J. Spiegel, Stuart W. Peltz, Temitayo Ajayi, Steven M. Rowe
Related Papers
- [Hemorrhagic diathesis in a 5-week-old infant with cystic fibrosis].(1996)
- → P349 Influence of spirometry technology on lung function measurements in adults with cystic fibrosis(2019)
- → P172 Different spirometry equipment produces clinically important differences in lung function measurements in adults with cystic fibrosis(2020)
- → P105 Home spirometry is reliable and of consistent quality in children with cystic fibrosis(2022)
- → (45) Vertical Asthma Hospital Pathway is Cost Effective in Decreasing LOS in Asthma in a Community PICU(2018)